INTRAVITREAL TRIAMCINOLONE AS PRIMARY TREATMENT OF CYSTOID MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION

To describe six patients treated with intravitreal triamcinolone (IVT) as primary therapy for cystoid macular edema (CME) secondary to branch retinal vein occlusion (BRVO).Retrospective case series.The age of the patients ranged from 53 years to 87 years (mean, 66 years). The time between BRVO and treatment with IVT ranged from 2.0 months to 4.7 months (mean, 3.5 months). Pretreatment visual acuity ranged from 20/40 to 6/200 (mean, 20/166)....